Literature DB >> 23400258

Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture.

Tsukasa Kamakura1, Takeru Makiyama, Kenichi Sasaki, Yoshinori Yoshida, Yimin Wuriyanghai, Jiarong Chen, Tetsuhisa Hattori, Seiko Ohno, Toru Kita, Minoru Horie, Shinya Yamanaka, Takeshi Kimura.   

Abstract

BACKGROUND: In the short- to mid-term, cardiomyocytes generated from human-induced pluripotent stem cells (hiPSC-CMs) have been reported to be less mature than those of adult hearts. However, the maturation process in a long-term culture remains unknown. METHODS AND
RESULTS: A hiPSC clone generated from a healthy control was differentiated into CMs through embryoid body (EB) formation. The ultrastructural characteristics and gene expressions of spontaneously contracting EBs were analyzed through 1-year of culture after cardiac differentiation was initiated. The 14-day-old EBs contained a low number of myofibrils, which lacked alignment, and immature high-density Z-bands lacking A-, H-, I-, and M-bands. Through the long-term culture up to 180 days, the myofibrils became more tightly packed and formed parallel arrays accompanied by the appearance of mature Z-, A-, H-, and I-bands, but not M-bands. Notably, M-bands were finally detected in 360-day-old EBs. The expression levels of the M-band-specific genes in hiPSC-CMs remained lower in comparison with those in the adult heart. Immunocytochemistry indicated increasing number of MLC2v-positive/MLC2a-negative cells with decreasing number of MLC2v/MLC2a double-positive cells, indicating maturing of ventricular-type CMs.
CONCLUSIONS: The structural maturation process of hiPSC-CMs through 1-year of culture revealed ultrastructural sarcomeric changes accompanied by delayed formation of M-bands. Our study provides new insight into the maturation process of hiPSC-CMs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400258     DOI: 10.1253/circj.cj-12-0987

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  117 in total

1.  Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.

Authors:  Gwanghyun Jung; Giovanni Fajardo; Alexandre J S Ribeiro; Kristina Bezold Kooiker; Michael Coronado; Mingming Zhao; Dong-Qing Hu; Sushma Reddy; Kazuki Kodo; Krishna Sriram; Paul A Insel; Joseph C Wu; Beth L Pruitt; Daniel Bernstein
Journal:  FASEB J       Date:  2015-12-16       Impact factor: 5.191

Review 2.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

Review 3.  Stem cells and stem cell-derived tissues and their use in safety assessment.

Authors:  Kyle Kolaja
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 4.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Karim Sallam; Yingxin Li; Philip T Sager; Steven R Houser; Joseph C Wu
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 5.  Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.

Authors:  Shin Kadota; Yuji Shiba
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

Review 6.  Three-dimensional scaffold-free microtissues engineered for cardiac repair.

Authors:  Alejandra Patino-Guerrero; Jaimeson Veldhuizen; Wuqiang Zhu; Raymond Q Migrino; Mehdi Nikkhah
Journal:  J Mater Chem B       Date:  2020-07-29       Impact factor: 6.331

Review 7.  Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.

Authors:  Patrizia Dell'Era; Patrizia Benzoni; Elisabetta Crescini; Matteo Valle; Er Xia; Antonella Consiglio; Maurizio Memo
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

8.  Human-induced pluripotent stem cell-derived cardiomyocytes for studies of cardiac ion transporters.

Authors:  Michael Fine; Fang-Min Lu; Mei-Jung Lin; Orson Moe; Hao-Ran Wang; Donald W Hilgemann
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-26       Impact factor: 4.249

9.  Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation.

Authors:  Padmini Sirish; Ning Li; Valeriy Timofeyev; Xiao-Dong Zhang; Lianguo Wang; Jun Yang; Kin Sing Stephen Lee; Ahmed Bettaieb; Sin Mei Ma; Jeong Han Lee; Demetria Su; Victor C Lau; Richard E Myers; Deborah K Lieu; Javier E López; J Nilas Young; Ebenezer N Yamoah; Fawaz Haj; Crystal M Ripplinger; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

Review 10.  Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.

Authors:  Shi Hua Tan; Lei Ye
Journal:  J Cardiovasc Transl Res       Date:  2018-03-19       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.